EEntrepreneurship Read More Join Sept. 18 with George Church and this year’s top biotech startupsAugust 13, 2025 I asked AI the other day how many biotechs have been co-founded by Harvard’s George Church. About 50…
GGenetics Read More Opus Genetics Announces Financial Results for Second Quarter 2025 and Provides Corporate UpdateAugust 13, 2025 Opus Genetics, Inc. – Positive 12-month Phase 1/2 clinical data in adult cohort and early pediatric clinical data…
GGenetics Read More Genetic insights into the origin, admixture, and migration of the early Austronesian peoplesAugust 7, 2025 Shutler R, Marck JC. On the dispersal of the Austronesian horticulturalists. Archaeology Phys Anthropol Ocean. 1975;10:81–113. Google Scholar …
GGenetics Read More When ganglioside pathways go awry: congenital disorders and experimental insightsJuly 31, 2025 Thudichum JLW. A treatise on the chemical constitution of the brain: Bailliere, Tindall, and Cox, London; 1884. Chiricozzi…
BBusiness Read More FDA vaccine chief Vinay Prasad leaves following criticism from Laura LoomerJuly 30, 2025 WASHINGTON (AP) — The Food and Drug Administration’s polarizing vaccine chief is leaving the agency after a brief…
GGenetics Read More Rocket’s PKP2-Arrhythmogenic Cardiomyopathy Gene Therapy RP-A601 Snags RMAT DesignationJuly 29, 2025 Rocket Pharmaceuticals’ RP-A601, an investigational adeno-associated virus (AAV) vector-based gene therapy intended to treat plakophilin-2 related Arrhythmogenic Cardiomyopathy…
GGenetics Read More Breakthrough gene therapy reverses genetic deafness across age groupsJuly 23, 2025 Using gene therapy to treat hereditary deafness is safe and effective in both children and adults, according to…
GGenetics Read More Molecular genetics of J-domain protein-related chaperonopathies in skeletal muscleJuly 22, 2025 Kampinga HH, Andreasson C, Barducci A, Cheetham ME, Cyr D, Emanuelsson C, et al. Function, evolution, and structure…
GGenetics Read More Sequencing validates deep learning models for EHR-based detection of Noonan syndrome in pediatric patientsJuly 21, 2025 Cohort characteristics and model risk score distribution The study cohort comprised 92,493 patients enrolled in the DT Biobank…
FFort Worth Read More Nanoscope Begins FDA Submission for Breakthrough Retinitis Pigmentosa TherapyJuly 14, 2025 Dallas-based Nanoscope Therapeutics has taken a major step toward offering new hope to people who are losing their…